Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Henry Reaction Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel chiral phosphonous bis-amino-oxazoline copper complex enables 98% yield in Henry reactions, offering reliable pharmaceutical intermediate supply.
Patent CN106008611B details a novel chiral cobalt complex enabling high conversion Henry reactions with simplified synthesis for reliable supply chains.